This lack of effect on CD64 is likely because THP-1 cells are SAM domain and HD domain-containing protein 1 (SAMHD1)-proficient AML cells, which are described as being better able to counteract changes in the dNTP pool induced by the drug treatment (32). This evidence concerns the gene SAMHD1 and acute myeloid leukemia.